SamaCare, a San Francisco, CA-based provider of a cloud-based patient access platform for specialty medications, raised $17M in Series B funding.
The round was led by Questa Capital, with participation from existing investors Vive Collective and South Park Commons.
The company intends to use the funds to accelerate product development of its one-stop patient access platform.
Led by CEO and Founder Syam Palakurthy, SamaCare provides pharmaceutical manufacturers, providers, payors, and other stakeholders with a cloud-based workflow automation platform for medical practices to streamline specialty drug prior authorization, enrollment, and benefit verification. In addition, it delivers premium services and data analytics for pharmaceutical brands to improve access to therapy.
SamaCare currently works with retina, oncology, neurology, and rheumatology practices that account for over $20 Billion in annual specialty drug spend and continues to grow quickly.
FinSMEs
21/05/2024